Doctor profile · Federal record
Dr. Mark Cascione, M.D.
Neurology Physician (CMS: Neurology) · Tampa, FL
- NPI 1447249115
- Accepts Medicare
- MIPS 74.1 / 100 · 2023
- 35 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2919 W Swann Ave, Suite 401
Tampa, FL 336094038
(813) 872-1548
fax (813) 872-7509 - Mailing address
-
9960 Nw 116Th Way Ste 13
Medley, FL 331781175
Credentials & registration
- NPI registered
- October 2005 — 21 yrs on file
- Profile last updated
- March 24, 2021
- Year of graduation
- 1991 — 35 yrs since
- Specialty taxonomy
- 2084N0400X — NUCC code
- State license (1)
- Florida #ME70673
- Medicaid
- FL #250401400
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1447249115. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
37,165
Distinct HCPCS
8
Medicare allowed
$2,177,102
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2350 |
Injection, ocrelizumab, 1 mg | 36,600 | 34 | $58 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 130 | 47 | $123 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 129 | 90 | $175 | |
96415 |
Administration of chemotherapy into vein, each additional hour | 112 | 40 | $26 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 78 | 66 | $124 | |
J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg | 62 | 27 | $5 | |
96375 |
Injection of additional new drug or substance into vein | 29 | 23 | $15 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 25 | 24 | $82 |
In context: peer comparison
Among 32 peers in this city , average services per provider: 575. This provider delivers 65× the peer median.Open Payments
Industry payments received
All-time total
$132,504
Transactions
310
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 25 | $29,921.72 | |
| GENZYME CORPORATION | 20 | $26,884.52 | |
| TG Therapeutics, Inc. | 21 | $25,446.66 | |
| Biogen, Inc. | 35 | $24,181.90 | |
| Vanda Pharmaceuticals Inc. | 11 | $8,144.63 | |
| Novartis Pharmaceuticals Corporation | 32 | $6,082.43 | |
| Celgene Corporation | 43 | $3,943.58 | |
| EMD Serono, Inc. | 11 | $2,621.30 | |
| ABBVIE INC. | 27 | $550.18 | |
| PFIZER INC. | 24 | $513.60 | |
| Octapharma USA, Inc. | 6 | $427.97 | |
| Genentech USA, Inc. | 14 | $375.00 | |
| Lundbeck LLC | 17 | $356.71 | |
| UCB, Inc. | 12 | $323.80 | |
| Alexion Pharmaceuticals, Inc. | 12 | $288.20 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,379
Patients
260
Total drug cost
$836,524
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Gabapentin | Generic | 194 | 40 | $4,760 |
| Baclofen | Generic | 160 | 38 | $6,912 |
| Alprazolam | Generic | 133 | 17 | $919 |
| Tizanidine Hcl | Generic | 115 | 26 | $2,692 |
| Dalfampridine Er (Dalfampridine) | Brand | 104 | 18 | $93,126 |
| Carbamazepine | Generic | 92 | 19 | $5,046 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 81 | 15 | $1,941 |
| Clonazepam | Generic | 76 | 12 | $903 |
| Zolpidem Tartrate | Generic | 74 | 0 | $748 |
| Aubagio (Teriflunomide) | Brand | 71 | 11 | $714,033 |
Hospital affiliations
Frequently asked questions
What is Dr. Mark Cascione's medical specialty?
Dr. Mark Cascione practices Neurology Physician in Tampa, FL.
Where does Dr. Mark Cascione practice?
Dr. Mark Cascione practices at 2919 W Swann Ave, Tampa, FL 336094038. Office phone: 8138721548.
What is Dr. Mark Cascione's NPI?
Dr. Mark Cascione's National Provider Identifier (NPI) is 1447249115, issued by NPPES.
Does Dr. Mark Cascione accept Medicare assignment?
Yes. Dr. Mark Cascione accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Cascione commonly perform?
Top Medicare-reported procedures in 2023: Injection, ocrelizumab, 1 mg (HCPCS J2350); Administration of chemotherapy into vein (HCPCS 96413); Established patient office or other outpatient visit (HCPCS 99215). Source: CMS Medicare Physician & Other Practitioners file.